| JYHZ2400281 | 利奈唑胺葡萄糖注射液 | linezolid | Injection | Chemical Drugs | License Renew | 2024-10-25 | | Pfizer AS;Pfizer Investment Co Ltd;HP Halden Pharma AS | | | view |
| JYHZ2000090 | 利奈唑胺葡萄糖注射液 | linezolid | Injection | Chemical Drugs | License Renew | 2020-05-06 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd;Fresenius Kabi Norge AS;Pfizer AS | Certificate Issued | 2020-10-14 | view |
| JYHZ2000039 | 利奈唑胺葡萄糖注射液 | linezolid | Injection | Chemical Drugs | License Renew | 2020-03-25 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd;Fresenius Kabi Norge AS;Pfizer AS | Certificate Issued | 2021-01-19 | view |
| JYHS2101000 | 利奈唑胺葡萄糖注射液 | linezolid | Injection | Chemical Drugs(5.2) | Import Drug Application | 2021-04-07 | | Nang Kuang Pharmaceutical Co Ltd;Beijing Yidu Zhengkang Health Technology Co Ltd | | | view |
| JYHS2000050 | 利奈唑胺葡萄糖注射液 | linezolid | Injection | Chemical Drugs(5.2) | Import Drug Application | 2020-12-25 | 北京费森尤斯卡比医药有限公司 | Beijing Fresenius Kabi Pharmaceutical Company Limited;Fresenius Kabi Norge AS;Fresenius Kabi Deutschland GmbH | In Review | 2020-12-23 | view |
| JYHB2400576 | 利奈唑胺葡萄糖注射液 | linezolid | Injection | Chemical Drugs | Supplementary Application | 2024-10-31 | | Pfizer AS;HP Halden Pharma AS | | | view |
| JYHB2300558 | 利奈唑胺葡萄糖注射液 | linezolid | Injection | Chemical Drugs | Supplementary Application | 2023-09-23 | | Fresenius Kabi Norge AS;Pfizer AS | | | view |
| JYHB2300261 | 利奈唑胺葡萄糖注射液 | linezolid | Injection | Chemical Drugs | Supplementary Application | 2023-04-22 | | Fresenius Kabi Norge AS;Pfizer AS | | | view |
| JYHB2300260 | 利奈唑胺葡萄糖注射液 | linezolid | Injection | Chemical Drugs | Supplementary Application | 2023-04-22 | | Fresenius Kabi Norge AS;Pfizer AS | | | view |
| JYHB2200144 | 利奈唑胺葡萄糖注射液 | linezolid | Injection | Chemical Drugs | Supplementary Application | 2022-03-23 | | Fresenius Kabi Norge AS;Pfizer AS | | | view |
| JYHB2200143 | 利奈唑胺葡萄糖注射液 | linezolid | Injection | Chemical Drugs | Supplementary Application | 2022-03-23 | | Fresenius Kabi Norge AS;Pfizer AS | | | view |
| JYHB2101548 | 利奈唑胺葡萄糖注射液 | linezolid | Injection | Chemical Drugs | Supplementary Application | 2021-11-24 | | Fresenius Kabi Norge AS;Pfizer AS | | | view |
| JYHB2101547 | 利奈唑胺葡萄糖注射液 | linezolid | Injection | Chemical Drugs | Supplementary Application | 2021-11-24 | | Fresenius Kabi Norge AS;Pfizer AS | | | view |
| JYHB2101143 | 利奈唑胺葡萄糖注射液 | linezolid | Injection | Chemical Drugs | Supplementary Application | 2021-05-28 | | Fresenius Kabi Norge AS;Pfizer AS | | | view |
| JYHB2101142 | 利奈唑胺葡萄糖注射液 | linezolid | Injection | Chemical Drugs | Supplementary Application | 2021-05-28 | | Fresenius Kabi Norge AS;Pfizer AS | | | view |
| JYHB2101035 | 利奈唑胺葡萄糖注射液 | linezolid | Injection | Chemical Drugs | Supplementary Application | 2021-04-10 | | Fresenius Kabi Norge AS;Pfizer AS | | | view |
| JYHB2101034 | 利奈唑胺葡萄糖注射液 | linezolid | Injection | Chemical Drugs | Supplementary Application | 2021-04-10 | | Fresenius Kabi Norge AS;Pfizer AS | | | view |
| JYHB2100102 | 利奈唑胺葡萄糖注射液 | linezolid | Injection | Chemical Drugs | Supplementary Application | 2021-01-28 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd;Fresenius Kabi Norge AS;Pfizer AS | In Review | 2021-01-27 | view |
| JYHB2001523 | 利奈唑胺葡萄糖注射液 | linezolid | Injection | Chemical Drugs | Supplementary Application | 2020-08-20 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd;Fresenius Kabi Norge AS;Pfizer AS | Filed | 2020-09-01 | view |
| JYHB2000045 | 利奈唑胺葡萄糖注射液 | linezolid | Injection | Chemical Drugs | Supplementary Application | 2020-02-10 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd;Fresenius Kabi Norge AS;Pfizer AS | Certificate Issued | 2020-04-21 | view |
